CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis

Journal of Investigative Dermatology

Volumn 133, Issue 11, 2013, Pages 2530-2537

  Takekoshi, Tomonori ^a,b   Wu, Xuesong ^a   Mitsui, Hiroshi ^b   Tada, Yayoi ^b   Kao, Mandy C ^a   Sato, Shinichi ^b   Dwinell, Michael B ^a   Hwang, Sam T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 22; INTERLEUKIN 23; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EAR EDEMA; GENE LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SKIN EDEMA; TH17 CELL; TRANSGENIC MOUSE;

EID: 84885960571     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.151     Document Type: Article

References (38)

1. Avniel S, Arik Z, Maly A et al. (2006) Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol 126:468-76 (Pubitemid 43323185)
2. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4: 540-50 (Pubitemid 38868623)
3. Bleul CC, Farzan M, Choe H et al. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-33 (Pubitemid 26299570)
4. Boniface K, Bernard FX, Garcia M et al. (2005) IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174:3695-702 (Pubitemid 40354080)
5. Boukamp P, Petrussevska RT, Breitkreutz D et al. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-71 (Pubitemid 18089976)
6. Brantley EC, Benveniste EN (2008) Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 6:675-84
7. Chan JR, Blumenschein W, Murphy E et al. (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203:2577-87 (Pubitemid 44833335)
8. Dell'Agnola C, Biragyn A (2007) Clinical utilization of chemokines to combat cancer: the double-edged sword. Expert Rev Vaccines 6:267-83 (Pubitemid 46607460)
9. Fang L, Lee VC, Cha E et al. (2008) CCR7 regulates B16 murine melanoma cell tumorigenesis in skin. J Leukoc Biol 84:965-72
10. Fitch E, Harper E, Skorcheva I et al. (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9:461-7 (Pubitemid 350305203)
11. Garzon R, Soriano SF, Rodriguez-Frade JM et al. (2004) CXCR4-mediated suppressor of cytokine signaling up-regulation inactivates growth hormone function. J Biol Chem 279:44460-6 (Pubitemid 39430851)
12. Hedrick MN, Lonsdorf AS, Shirakawa AK et al. (2009) CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest 119: 2317-29
13. Horiuchi Y, Bae SJ, Katayama I (2006) Overexpression of the suppressor of cytokine signalling 3 (SOCS3) in severe atopic dermatitis. Clin Exp Dermatol 31:100-4
14. Kreis S, Philippidou D, Margue C et al. (2007) Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells. PLoS One 2:e1300
15. Linke A, Goren I, Bosl MR et al. (2010) The suppressor of cytokine signaling (SOCS)-3 determines keratinocyte proliferative and migratory potential during skin repair. J Invest Dermatol 130:876-85
16. Lonsdorf AS, Hwang ST, Enk AH (2009) Chemokine receptors in T-cellmediated diseases of the skin. J Invest Dermatol 129:2552-66
17. Mabuchi T, Chang TW, Quinter S et al. (2012) Chemokine receptors in the pathogenesis and therapy of psoriasis. J Dermatol Sci 65:4-11
18. Mabuchi T, Takekoshi T, Hwang ST (2011) Epidermal CCR6\+ gammadelta T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol 187:5026-31
19. Mansbridge JN, Knapp AM (1987) Changes in keratinocyte maturation during wound healing. J Invest Dermatol 89:253-63 (Pubitemid 17135369)
20. Murakami T, Cardones AR, Finkelstein SE et al. (2003) Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 198:1337-47 (Pubitemid 37392479)
21. Murakami T, Maki W, Cardones AR et al. (2002) Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62:7328-34 (Pubitemid 36025256)
22. Nagy A (2000) Cre recombinase: the universal reagent for genome tailoring. Genesis 26:99-109 (Pubitemid 30158089)
23. Nakagawa R, Yoshida H, Asakawa M et al. (2011) Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17. J Immunol 187:4611-20
24. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496-509
25. Petit I, Szyper-Kravitz M, Nagler A et al. (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687-94 (Pubitemid 34752479)
26. Romanowska M, Reilly L, Palmer CN et al. (2010) Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo. PLoS One 5:e9701
27. Rosenberger C, Solovan C, Rosenberger AD et al. (2007) Upregulation of hypoxia-inducible factors in normal and psoriatic skin. J Invest Dermatol 127:2445-52 (Pubitemid 47619751)
28. Salgado CG, Nakamura K, Sugaya M et al. (1999) Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidermal langerhans cells1. J Invest Dermatol 113:1021-7 (Pubitemid 30013347)
29. Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352:1899-912 (Pubitemid 40627816)
30. Sestito R, Madonna S, Scarponi C et al. (2011) STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J 25:916-27
31. Staller P, Sulitkova J, Lisztwan J et al. (2003) Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425:307-11 (Pubitemid 37158407)
32. Urbich C, Dimmeler S (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95:343-53 (Pubitemid 39100452)
33. Veldkamp CT, Ziarek JJ, Su J et al. (2009) Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12. Protein Sci 18:1359-69
34. Weiss G, Shemer A, Trau H (2002) The Koebner phenomenon: review of the literature. J Eur Acad Dermatol Venereol 16:241-8 (Pubitemid 34785321)
35. Wilson NJ, Boniface K, Chan JR et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8:950-7 (Pubitemid 47300009)
36. Yamaguchi J, Kusano KF, Masuo O et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322-8 (Pubitemid 36314418)
37. Zheng Y, Danilenko DM, Valdez P et al. (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648-51 (Pubitemid 46232884)
38. Zimmerman NP, Vongsa RA, Faherty SL et al. (2011) Targeted intestinal epithelial deletion of the chemokine receptor CXCR4 reveals important roles for extracellular-regulated kinase-1/2 in restitution. Lab Invest 91:1040-55